The Impact of Intrathecal Baclofen Therapy on Health-related Quality of Life for Children with Marked Hypertonia

References

• Houlihan CM, O’Donnell M, Conaway M, Stevenson RD. Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol. 2004;46:305–10. doi:10.1111/j.1469-8749.2004.tb00490.x.
   PubMed Web of Science ®Google Scholar
• Ramstad K, Jahnsen R, Skjeldal OH, Diseth TH. Characteristics of recurrent musculoskeletal pain in children with cerebral palsy aged 8 to 18 years. Dev Med Child Neurol. 2011;53:1013–18. doi:10.1111/j.1469-8749.2011.04070.x.
   PubMed Web of Science ®Google Scholar
• Graham D, Paget SP, Wimalasundera N. Current thinking in the health care management of children with cerebral palsy. Med J Aust. 2019;210(3):129–35. doi:10.5694/mja2.12106.
   PubMed Web of Science ®Google Scholar
• Nahm NJ, Graham HK, Gormley ME Jr, Georgiadis AG. Management of hypertonia in cerebral palsy. Curr Opin Pediatr. 2018;30(1):57–64. doi:10.1097/MOP.0000000000000567.
   PubMed Web of Science ®Google Scholar
• Penn R, Kroin J. Continuous intrathecal baclofen for severe spasticity. The Lancet. 1985;326:125–27. doi:10.1016/S0140-6736(85)90228-4.
   Google Scholar
• Buizer AI, Martens BH. Grandbois van Ravenhorst C, Schoonmade LJ, Becher JG, Vermeulen RJ. Effect of continuous intrathecal baclofen therapy in children: a systematic review. Dev Med Child Neurol. 2019;61:128–34. doi:10.1111/dmcn.14005.
   PubMed Web of Science ®Google Scholar
• Hasnat MJ, Rice JE. Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cochrane Database Sys Rev. 2015;11:CD004552.
   Google Scholar
• World health Organization (WHO). International classification of functioning, disability and health: ICF. Geneva, Switzerland: World Health Organization; 2001.
   Google Scholar
• Stewart K, Hutana G, Kentish M. Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit. BMJ Open. 2017;7(6):e015863. doi:10.1136/bmjopen-2017-015863.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res. 1993;2:153–59. doi:10.1007/BF00435734.
   PubMed Web of Science ®Google Scholar
• Narayanan U. Keynote address european academy of childhood disability. Stockholm; 2016.
   Google Scholar
• Narayanan U, Weir S, Fehlings D The CPCHILD© manual and interpretation guide. 2007.Available at Hospital for Sick Children website: http://www.sickkids.ca
   Google Scholar
• Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006;48(10):804–12. doi:10.1017/S0012162206001745.
   PubMed Web of Science ®Google Scholar
• Liew PY, Stewart K, Khan D, Arnup SJ, Scheinberg A. Intrathecal baclofen therapy in children: an analysis of individualized goals. Dev Med Child Neurol. 2018;60(4):367–73. doi:10.1111/dmcn.13660.
   PubMed Web of Science ®Google Scholar
• Albright AL, Barry MJ, Shafron DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001;43(10):652–57. doi:10.1017/S0012162201001190.
   PubMed Web of Science ®Google Scholar
• Baker KW, Tann B, Mutlu A, Gaebler-Spira D. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ). J Child Neurol. 2014;29(3):312–17. doi:10.1177/0883073812475156.
   PubMed Web of Science ®Google Scholar
• Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Dev Med Child Neurol. 2004;46:548–52. doi:10.1111/j.1469-8749.2004.tb01013.x.
   PubMed Web of Science ®Google Scholar
• Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Becher JG, Vles JS. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial. Europ J Paediatr Neurol. 2009;13:240–46. doi:10.1016/j.ejpn.2008.04.013.
   PubMed Web of Science ®Google Scholar
• Hoving MA, Van Raak EP, Spincemaille GH, Palmans LJ, Sleypen FA, Vles JS. Intrathecal baclofen in children with spastic cerebral palsy: a double‐blind, randomized, placebo‐controlled, dose‐finding study. Dev Med Child Neurol. 2007;49:654–59. doi:10.1111/j.1469-8749.2007.00654.x.
   PubMed Web of Science ®Google Scholar
• Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, Ward JD, Bloom KK, Brooks WH, Madsen JR, et al. GMFM 1 year after continuous intrathecal baclofen infusion. Pediatr Rehabil. 2005;8:207–13. doi:10.1080/13638490400021479.
   PubMedGoogle Scholar
• Morton RE, Gray N, Vloeberghs M. Controlled study of the effects of continuous intrathecal baclofen infusion in non‐ambulant children with cerebral palsy. Dev Med Child Neurol. 2011;53:736–41. doi:10.1111/j.1469-8749.2011.04009.x.
   PubMed Web of Science ®Google Scholar
• Motta F, Antonello CE, Stignani C. Intrathecal baclofen and motor function in cerebral palsy. Dev Med Child Neurol. 2011;53(5):443–48. doi:10.1111/j.1469-8749.2010.03904.x.
   PubMedGoogle Scholar
• Motta F, Stignani C, Antonello CE. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. J Pediatr Orthop. 2008;28:213–17. doi:10.1097/BPO.0b013e3181653b2a.
   PubMed Web of Science ®Google Scholar
• Overgard TM, Kjaersgaard-Hansen L, Soe M, Illum NO. Positive experience with intrathecal baclofen treatment in children with severe cerebral palsy. Dan Med J. 2015;62:A4999.
   PubMed Web of Science ®Google Scholar
• Vles GF, Soudant DL, Hoving MA, Vermeulen RJ, Bonouvrie LA, van Oostenbrugge RJ, Vles JS. Long-term follow-up on continuous intrathecal baclofen therapy in non-ambulant children with intractable spastic cerebral palsy. Eur J Paediatr Neurol. 2013;17(6):639–44. doi:10.1016/j.ejpn.2013.06.003.
   PubMed Web of Science ®Google Scholar
• Ward A, Hayden S, Dexter M, Scheinberg A. Continuous intrathecal baclofen for children with spasticity and/or dystonia: goal attainment and complications associated with treatment. J Paediatr Child Health. 2009;45(12):720–26. doi:10.1111/j.1440-1754.2009.01601.x.
   PubMed Web of Science ®Google Scholar
• Kraus T, Gegenleitner K, Svehlik M, Novak M, Steinwender G, Singer G. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy. Europ J Paediatr Neurol. 2017;21:565–69. doi:10.1016/j.ejpn.2017.01.016.
   PubMed Web of Science ®Google Scholar
• Palisano R, Rosenbaum P, Walters SD, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–23. doi:10.1111/j.1469-8749.1997.tb07414.x.
   PubMed Web of Science ®Google Scholar
• Eliasson AC, Krumlinde-Sundholm L, Rosblad B, Beckung E, Arner M, Ohrvall AM, Rosenbaum P. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006;48:549–54. doi:10.1017/S0012162206001162.
   PubMed Web of Science ®Google Scholar
• Hidecker MJ, Paneth N, Rosenbaum PL, Kent RD, Lillie J, Eulenberg JB, Chester K Jr., Johnson B, Michalsen L, Evatt M, et al. Developing and validating the communication function classification system for individuals with cerebral palsy. Dev Med Child Neurol. 2011;53:704–10. doi:10.1111/j.1469-8749.2011.03996.x.
   PubMed Web of Science ®Google Scholar
• Jethwa A, Mink J, Macarthur C, Knights S, Fehlings T, Fehlings D. Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children. Dev Med Child Neurol. 2010;52:e83–7. doi:10.1111/j.1469-8749.2009.03483.x.
   PubMed Web of Science ®Google Scholar
• Bohtz C, Meyer-Heim A, Min K. Changes in health-related quality of life after spinal fusion and scoliosis correction in patients with cerebral palsy. J Pediatr Orthop. 2011;31:668–73. doi:10.1097/BPO.0b013e318221093c.
   PubMed Web of Science ®Google Scholar
• Miller DJ, Flynn JJM, Pasha S, Yaszay B, Parent S, Asghar J, Abel MF, Pahys JM, Samdani A, Hwang SW. Improving health-related quality of life for patients with nonambulatory cerebral palsy: who stands to gain from scoliosis surgery? J Pediatr Orthop. 2019.
   Web of Science ®Google Scholar
• Krach L, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatr Rehabil. 2006;9:210–18. doi:10.1080/13638490500138678.
   PubMedGoogle Scholar
• Allison PJ, Locker D, Feine JS. Quality of life: a dynamic construct. Soc Sci Med. 1997;45:221–30. doi:10.1016/S0277-9536(96)00339-5.
   PubMed Web of Science ®Google Scholar
• McPhail S, Haines T. Response shift, recall bias and their effect on measuring change in health-related quality of life amongst older hospital patients. Health Qual Life Out. 2010;8:65. doi:10.1186/1477-7525-8-65.
   PubMed Web of Science ®Google Scholar
• Himmelmann K, McManus V, Hagberg G, Uvebrant P, Krägeloh-Mann I, Cans C. Dyskinetic cerebral palsy in Europe: trends in prevalence and severity. A Dis Childhood. 2009;94:921–26. doi:10.1136/adc.2008.144014.
   PubMed Web of Science ®Google Scholar
• Monbaliu E, La Peña D, Ortibus E, Molenaers G, Deklerck J, Feys H. Functional outcomes in children and young people with dyskinetic cerebral palsy. Dev Med Child Neurol. 2017;59(6):634–40. doi:10.1111/dmcn.13406.
   PubMed Web of Science ®Google Scholar